What Is the Cost of Tirzepatide Per Month?

Reading time
7 min
Published on
May 12, 2026
Updated on
May 13, 2026
What Is the Cost of Tirzepatide Per Month?

Introduction

Tirzepatide costs roughly $349 to $1,349 per month in the United States, depending on the brand, dose, your insurance, and your source. Zepbound® (Eli Lilly’s weight-loss brand) lists at $1,059 to $1,349 per month for the pen-injector. Lilly’s single-dose vial program offers Zepbound at $349 to $499 per month for patients paying cash. Mounjaro® (the diabetes brand) lists around $1,069 per month for any dose strength.

Compounded tirzepatide from licensed pharmacies runs about $300 to $500 per month. With commercial insurance plus manufacturer savings cards, branded options can drop to $25 to $300 monthly for eligible patients. Medicare doesn’t cover tirzepatide for obesity as of 2026.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the List Price of Zepbound?

Eli Lilly lists Zepbound’s wholesale acquisition cost at about $1,059 per month for the auto-injector pens. With the higher 15 mg dose pen, retail pharmacy pricing can reach $1,200 to $1,349 per month. List prices don’t reflect what most patients pay. Insurance, manufacturer coupons, and direct vial programs all reduce the actual cost.

Quick Answer: Zepbound list price is $1,059 to $1,349 per month, varying by dose

The price is similar to Wegovy®’s $1,349 list and substantially higher than older obesity drugs like phentermine ($30 to $60 per month). The pricing reflects the trial costs, manufacturing complexity, and patent protection on tirzepatide.

How Much Does Mounjaro Cost Per Month?

Mounjaro’s list price is around $1,069 per month regardless of dose. Insurance coverage for type 2 diabetes is broader than for obesity, so Mounjaro is more commonly covered. Eligible commercial-insured patients can use the Mounjaro Savings Card to pay as little as $25 per month.

Patients without diabetes who get Mounjaro off-label typically face higher out-of-pocket costs because the savings card requires a diabetes prescription.

What Is Lilly’s Direct-to-consumer Zepbound Program?

In August 2024, Eli Lilly launched LillyDirect, which offers single-dose Zepbound vials at lower cash prices. The 2.5 mg vial costs $349 per month, 5 mg vial costs $499 per month, 7.5 mg costs $599, and 10 mg costs $699 per month. The vials require a slightly different injection technique using a separate syringe rather than the auto-injector pen.

The program targets uninsured or underinsured patients without manufacturer savings card access. Patients in the LillyDirect program also get free shipping and access to telehealth providers if needed.

How Does Compounded Tirzepatide Compare on Price?

Compounded tirzepatide from licensed 503A or 503B pharmacies typically costs $300 to $500 per month. Pricing varies by dose, compounding pharmacy, and the telehealth platform organizing the prescription. Most compounded programs include a flat monthly fee that covers the medication, prescriber consultation, and shipping.

TrimRx offers compounded tirzepatide through a free assessment quiz that matches medical eligibility with appropriate dosing. Patients without insurance coverage often choose compounded routes for predictable monthly costs.

Does Insurance Cover Zepbound?

Commercial insurance coverage for Zepbound is improving but inconsistent. As of early 2026, roughly 30 to 40% of commercial plans cover Zepbound for adults meeting the on-label BMI criteria, usually with prior authorization. Coverage is more common for plans with obesity-specific benefit riders. Some plans require step therapy: documented response or failure on cheaper agents (phentermine, semaglutide) before approving tirzepatide.

Medicare doesn’t cover Zepbound for obesity. Medicare can cover Mounjaro for type 2 diabetes. The OSA approval from December 2024 has prompted some Medicare Advantage plans to start covering Zepbound for patients with documented moderate-to-severe OSA and obesity.

What Manufacturer Savings Cards Are Available?

The Zepbound Savings Card brings the cost to as low as $25 per month for eligible commercial-insured patients with coverage, or about $650 per month for those without coverage but with commercial insurance. The card has annual maximum benefits and excludes Medicare, Medicaid, and other government program patients.

Mounjaro Savings Card has similar mechanics: $25 per month with coverage, capped annual benefits. Both cards require a valid prescription and eligibility verification through Lilly’s portal.

Key Takeaway: Mounjaro lists around $1,069 per month

Why Is Tirzepatide So Expensive?

Pricing reflects R&D recovery, complex manufacturing, supply constraints, and patent protection. Eli Lilly invested billions in the SURPASS and SURMOUNT trial programs. The molecule requires GMP-compliant peptide synthesis and sterile fill-finish, both of which have limited global capacity. Patent exclusivity in the US runs through at least 2036, blocking generic competition.

Demand has also outpaced supply since 2022. As supply caught up in 2024 to 2025, list prices haven’t fallen meaningfully, though direct-to-consumer programs have introduced effective lower price points.

Are There Cheaper Alternatives to Tirzepatide?

Yes, with different efficacy profiles. Semaglutide (Wegovy, Ozempic®) costs similarly to tirzepatide but produces somewhat less weight loss (14.9% vs 20.9% on average). Liraglutide (Saxenda®) is older and produces about 6 to 7% weight loss but costs $1,200 to $1,400 monthly. Phentermine and other older agents cost $30 to $80 per month but typically produce 4 to 6% weight loss.

For patients who need significant weight loss and can’t afford branded GLP-1s, compounded semaglutide or tirzepatide through licensed pharmacies often offers the best value-to-efficacy ratio.

What Hidden Costs Come with Tirzepatide?

Add to the medication price: prescriber visits ($75 to $250 each, often quarterly), labs (CBC, CMP, A1C, lipids every 6 to 12 months, $50 to $200 with or without insurance), syringes and alcohol pads if using vial-format ($10 to $30 monthly), and sharps disposal containers ($10 to $20 every few months).

A TrimRx subscription bundles prescriber oversight and shipping into the monthly fee, which simplifies cost planning for many patients.

Will Tirzepatide Get Cheaper?

Probably gradually. Lilly’s direct-to-consumer vial program already reduced the effective price for cash-paying patients. Generic competition won’t arrive before patent expiration in the mid-2030s. New GLP-1 entrants from competitors (oral orforglipron, retatrutide, and others) may pressure pricing as they reach market in 2026 to 2028.

Insurance coverage for obesity continues to expand. As employer-sponsored plans add obesity benefits, more patients will see lower out-of-pocket costs even without list price changes.

Bottom line: Insurance plus savings cards can bring out-of-pocket to $25 to $300

FAQ

What’s the Cheapest Way to Get Tirzepatide?

Lilly’s direct-to-consumer vial program at $349 to $499 per month for patients paying cash. Compounded tirzepatide from licensed pharmacies runs $300 to $500. With commercial insurance, the manufacturer savings card can bring costs to $25 per month.

Does Medicare Cover Zepbound?

Not for obesity as of 2026. Medicare can cover Mounjaro for type 2 diabetes. Some Medicare Advantage plans cover Zepbound for OSA after the December 2024 FDA expansion.

Why Is Mounjaro Cheaper Than Zepbound with Insurance?

Insurance coverage for diabetes is broader than for obesity. Same medication, different label, different formulary placement. The Mounjaro Savings Card works for many diabetic patients.

Can I Use My HSA for Tirzepatide?

Yes. Tirzepatide is a prescription medication and qualifies for HSA and FSA reimbursement. Save your receipts and provide a copy of the prescription if your account requires documentation.

Is Compounded Tirzepatide Cheaper Than Zepbound Vials?

Sometimes. Compounded options run $300 to $500 monthly. Zepbound vials run $349 to $699. The cheaper option depends on dose and the specific compounding pharmacy or telehealth platform.

Does the Price Include Needles and Syringes?

For Zepbound pen-injectors, yes. For Zepbound vials, you buy syringes separately. For compounded tirzepatide, the platform usually includes needles. Always confirm what’s included before subscribing.

How Often Do I Pay for Tirzepatide?

Monthly, in most cases. Some compounded programs offer quarterly billing with a discount. Pharmacy-dispensed Zepbound and Mounjaro are typically monthly refills tied to your prescription.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.

Related Articles

Transforming Lives, One Step at a Time

Patients on TrimRx can maintain the WEIGHT OFF
Start Your Treatment Now!

Keep reading

6 min read

Why Does Mounjaro Make You Tired: Fatigue Decoded

Mounjaro tiredness gets glossed over in the prescribing information, which lists fatigue at roughly 4 to 6 percent across the SURPASS trial program.

7 min read

How Much Weight Do You Lose on Tirzepatide in 6 Months?

Six-month tirzepatide weight loss averages roughly 12 to 18 percent of starting body weight at the higher maintenance doses (10 to 15 mg weekly).

7 min read

Can You Take Tirzepatide Without Diabetes?

Yes. Tirzepatide is FDA-approved for chronic weight management in non-diabetic adults under the brand name Zepbound.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.